I am a
Home I AM A Search Login

Papers of the Week

2022 Jun 28

Curr Opin Ophthalmol

Pilocarpine 1.25% and the changing landscape of presbyopia treatment.


Meghpara BB, Lee JK, Rapuano CJ, Mian SI, Ho AC
Curr Opin Ophthalmol. 2022 Jun 28.
PMID: 35786801.


Despite affecting approximately 1.8 billion individuals worldwide, until recently, a pharmacologic treatment for presbyopia was not available. This special commentary reviews the treatment of presbyopia with a focus on the recently approved medication Vuity (pilocarpine 1.25%, Allergan, an AbbVie Company).